Porquet D, Appel M, Fournier T, Bertaux O, Biou D, Féger J
U.F.R. des Sciences Pharmaceutiques et Biologiques, Département de Biochimie, Châtenay-Malabry, France.
Experientia. 1992 Mar 15;48(3):257-61. doi: 10.1007/BF01930469.
Both in vivo and in vitro models have certain disadvantages for the study of the chronic hepatotoxicity of drugs. The aim of this work was to evaluate a new approach based on an in vivo/in vitro model. After chronic in vivo treatment of rats with Vincamine and Vindeburnol (an eburnamenine derivative which exhibits hepatotoxic properties in man) liver cells were isolated, and functional and metabolic disorders (metabolic utilization of fructose and protein biosynthesis) were studied to determine injury. The results showed no modification of blood parameters, but a direct relationship between the dose of Vindeburnol administered in vivo and the metabolic disorders observed in vitro, evidencing the high sensitivity and reliability of this model.
体内和体外模型在药物慢性肝毒性研究中都有一定的缺点。这项工作的目的是评估一种基于体内/体外模型的新方法。在用长春胺和长春地辛(一种在人体中具有肝毒性的埃博霉素衍生物)对大鼠进行慢性体内治疗后,分离肝细胞,并研究功能和代谢紊乱(果糖的代谢利用和蛋白质生物合成)以确定损伤情况。结果显示血液参数没有改变,但体内给予长春地辛的剂量与体外观察到的代谢紊乱之间存在直接关系,证明了该模型的高敏感性和可靠性。